Arrowhead Research Corp

Type: Company
Name: Arrowhead Research Corp
First reported Sep 19 2014 - Updated Sep 19 2014 - 3 reports

Arrowhead to Present at BioCentury’s NewsMakers in the Biotech Industry Conference

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead’s chief operating officer, will present at BioCentury’s 21 st Annual NewsMakers…Click to ... [Published Fort Mills Times - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference

--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead's chief operating officer, will present at BioCentury's 21(st) Annual NewsMakers in the ... [Published Scottrade - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 3 reports

Arrowhead Research Shares Up 13.9% Since SmarTrend's Buy Recommendation (ARWR)

Written on Thu, 09/18/2014 - 12:50pmBy David DiazSmarTrend identified an Uptrend for Arrowhead Research ( NASDAQ:ARWR ) on August 14th, 2014 at $13.88. In approximately 1 month, Arrowhead Research has returned 13.95% as of today's recent price of $1 ... [Published Comtex SmarTrend - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Top 5 Companies in the Healthcare Sector with the Best Relative Performance (SLXP, HUM, CELG, GILD, ARWR)

Written on Tue, 09/16/2014 - 11:25amBy Nick RussoHere are the top 5 stocks in the Healthcare sector ranked by performance. We compiled the trading activity from today and then analyzed the sector looking for stocks that were outperforming. This is what ... [Published Comtex SmarTrend - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver

CHICAGO, Sept. 16, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INTC, ZNGA, ISIS, ARWR and MNKD.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ... [Published PR Newswire: Financial Services - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 2 reports

3 Biotech Breakout Charts That Could See More Upside

09/11/14 - 01:47 PM EDTNEW YORK ( TheStreet ) -- Strong charts continue to be found in this uncertain market, especially in the biotechs. Here are three to watch for more upside.Arrowhead Research   ( ARWR ) is in a bottoming pattern. It pulled back to ... [Published TheStreet.com - Sep 11 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Arrowhead Research Shares Climbing Higher, Up 4.1%

Written on Tue, 09/09/2014 - 11:11amBy Shiri GuptaArrowhead Research ( NASDAQ:ARWR ) is one of today's notable stocks on the rise, up 4.1% to $17.37. The S&P is currently trading 0.4% lower to 1,993 and the Dow Jones Industrial Average is trading 0.5% ... [Published Comtex SmarTrend - Sep 09 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

FRIDAY'S ETF MOVERS : Xlu, xbi

In trading on Friday, the Utilities Select Sector SPDR Fund ETF (XLU) is outperforming other ETFs, up about 0.8% on the day. Components of that ETF showing particular strength include shares of Xcel Energy (XEL), up about 1.5% and shares of PG&E (PCG), ... [Published 4 Traders - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 2 reports

Top 5 Companies in the Healthcare Sector with the Best Relative Performance (CLDX, OREX, ARWR, CI, WLP)

Written on Thu, 09/04/2014 - 11:25amBy Amy SchwartzWe looked at the Healthcare sector and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at today's ... [Published Comtex SmarTrend - Sep 04 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Friday's ETF Movers: XBI, PIZ

In trading on Friday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1% on the day. Components of that ETF showing particular strength include shares of United Therapeutics (UTHR), up about 15.9% and shares of Arrowhead Research ... [Published Street Sweeper - Aug 29 2014]
First reported Aug 26 2014 - Updated Aug 27 2014 - 2 reports

Tuesday's ETF Movers: XBI, XLU

at 13:15 PM EDT In trading on Tuesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.2% on the day. Components of that ETF showing particular strength include shares of Arrowhead Research (ARWR), up about 12.3% and shares of Isis ... [Published NewsOK.com - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 4 reports

Arrowhead Research is a prime acquisition target

Deutsche Bank analysts said that Arrowhead Research Corp. (Nasdaq: ARWR) was a good target for an acquisition sending the stock price up $1.76 to close at $15.2 ... [Published Chicago Daily Herald - Aug 26 2014]

Quotes

"We rate ARROWHEAD RESEARCH CORP (ARWR) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and weak operating cash flow." You can view the full analysis from the report here: ARWR Ratings Report
...the experimental realm into the clinical realm," David Lewis, chief scientific officer at Arrowhead Research in Madison, WI, said in the article.  "We're in a hugely exciting time right now. It's not often you get a chance to be part of a nascent field like this that will really make an impact on human medicine." Lewis's company is working on a hepatitis B treatment...
"If you want to compete with Gilead, you have to buy Achillion" Deutsche Bank's Robyn Karnauskas said on CNBC. "We think that's one take-out target."
Pioneer Natural Resources (NYSE:PXD): "The oil complex is going down. This is going down."

More Content

All (133) | News (88) | Reports (0) | Blogs (37) | Audio/Video (0) | Fact Sheets (0) | Press Releases (8)
sort by: Date | Relevance
Arrowhead to Present at BioCentury’s NewsMakers... [Published Fort Mills Times - Sep 19 2014]
Arrowhead to Present at BioCentury's NewsMakers... [Published Scottrade - Sep 19 2014]
Arrowhead to Present at BioCentury’s NewsMakers... [Published 4 Traders - Sep 19 2014]
Arrowhead to Present at BioCentury’s NewsMakers... [Published Business Wire Health News - Sep 19 2014]
Arrowhead Research Shares Up 13.9% Since SmarTr... [Published Comtex SmarTrend - Sep 18 2014]
Arrowhead Research Shares Up 13.9% Since SmarTr... [Published Individual.com - Sep 18 2014]
Leading Health Care Stock for Small-Cap Stars i... [Published Equities.com - Sep 17 2014]
Leading Small-Cap Stars Health Care Stock for S... [Published Equities.com - Sep 17 2014]
Arrowhead Research Corp Receives “Outperform” R... [Published Mideast Time - Sep 17 2014]
Stock Analysts’ Ratings Reiterations for Septem... [Published American Banking News - Sep 17 2014]
Top 5 Companies in the Healthcare Sector with t... [Published Comtex SmarTrend - Sep 16 2014]
Critical Alerts For Intel, Zynga, Isis Pharmace... [Published PR Newswire: Financial Services - Sep 16 2014]
Shares of Arrowhead Research Under Pressure, Do... [Published Individual.com - Sep 15 2014]
3 Biotech Breakout Charts That Could See More U... [Published TheStreet.com - Sep 11 2014]
3 Biotech Breakout Charts That Could See More U... [Published The Street Latest - Sep 11 2014]
Arrowhead Research Shares Up 22.4% Since SmarTr... [Published Individual.com - Sep 11 2014]
Arrowhead Research Shares Climbing Higher, Up 4.1% [Published Comtex SmarTrend - Sep 09 2014]
Relatively Good Performance Detected in Shares ... [Published Comtex SmarTrend - Sep 08 2014]
FRIDAY'S ETF MOVERS : Xlu, xbi [Published 4 Traders - Sep 05 2014]
Friday's ETF Movers: XLU, XBI [Published Forbes.com - Sep 05 2014]
Arrowhead Research Corp Heads Higher After Brea... [Published Benzinga.com - Sep 04 2014]
Top 5 Companies in the Healthcare Sector with t... [Published Comtex SmarTrend - Sep 04 2014]
18.4% Return Seen to Date on SmarTrend Arrowhea... [Published Individual.com - Sep 04 2014]
Technical Data on Biotech Stocks - ARIAD Pharma... [Published Financial Services - Sep 04 2014]
Leading Health Care Stock for Small-Cap Stars i... [Published Equities.com - Sep 03 2014]
Arrowhead Research Climbs +8.54% Midday, Is Up ... [Published Value Walk - Sep 03 2014]
Tg Therapeutics Inc. (TGTX) Leads Small-Cap Sta... [Published Equities.com - Sep 03 2014]
Leading Small-Cap Stars Health Care Stock for S... [Published Equities.com - Sep 03 2014]
Arrowhead Research Corp Shares Push Over Resist... [Published Benzinga.com - Sep 03 2014]
RNAi pipeline active as investors, patients wai... [Published Fierce Drug Delivery - Sep 03 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Arrowhead to Present at BioCentury’s NewsMakers... [Published Business Wire Health News - Sep 19 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York ...
Critical Alerts For Intel, Zynga, Isis Pharmace... [Published PR Newswire: Financial Services - Sep 16 2014]
CHICAGO, Sept. 16, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INTC, ZNGA, ISIS, ARWR and MNKD.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ...
Upcoming Conferences, Market Activity, Drug App... [Published PR Newswire: Entertainment & Media - Aug 29 2014]
NEW YORK, August 29, 2014 /PRNewswire/ --Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: ...
Critical Alerts For Arrowhead Research, Isis Ph... [Published PR Newswire: Financial Services - Aug 27 2014]
CHICAGO, Aug. 27, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ...
Arrowhead Reports Fiscal 2014 Third Quarter Fin... [Published Business Wire Health News - Aug 12 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on the Phase 2a study ARC-520 for the treatment of chronic hepatitis b infection ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
Technical Data on Biotech Stocks - ARIAD Pharma... [Published Financial Services - Sep 04 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
SEC Filings, Positive Trial Results, Technical ... [Published Financial Services - Jul 18 2014]
Technical Updates, License Agreements, and Acqu... [Published Financial Services - Jul 08 2014]
Clinical Studies, Trials Results, Appointments,... [Published Financial Services - Jun 27 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.